Back to Trades
Bowden Christopher
DirectorCIK 0001608601
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Bowden Christopher, Director, has disclosed $400.4K in transactions — all concentrated in Bicara Therapeutics Inc. (BCAX). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jun 10 | BCAX Bicara Therapeutics Inc. | Bowden Christopher | Director | Award | $400.4K |
1 filing